Ausgabe 1/2012
Inhalt (12 Artikel)
Lessons from ALL-REZ BFM 90: Therapy for Childhood Leukemia Based on Timing and Site of Relapse
Michael E. Rytting
Can Prognostic Factors Be Used to Direct Therapy in Chronic Lymphocytic Leukemia?
Leopold Sellner, Sascha Dietrich, Peter Dreger, Hanno Glimm, Thorsten Zenz
Immune Reconstitution in Chronic Lymphocytic Leukemia
John C. Riches, Alan G. Ramsay, John G. Gribben
Treatment of Older Patients with Chronic Lymphocytic Leukemia
Nicole Lamanna
Inhibiting B-Cell Receptor Signaling Pathways in Chronic Lymphocytic Leukemia
Jan A. Burger
Disordered Epigenetic Regulation in the Pathophysiology of Myeloproliferative Neoplasms
Su-Jiang Zhang, Omar Abdel-Wahab
Prognostication in Primary Myelofibrosis
Francisco Cervantes, Arturo Pereira
Management of Myeloproliferative Neoplasms: From Academic Guidelines to Clinical Practice
Giovanni Barosi, Letizia Lupo, Vittorio Rosti
Role of TET2 Mutations in Myeloproliferative Neoplasms
Elodie Pronier, François Delhommeau
What Happened to Anti-CD33 Therapy for Acute Myeloid Leukemia?
Joseph G. Jurcic
Management of Refractory Acute Myeloid Leukemia: Re-induction Therapy or Straight to Transplantation?
E. J. Feldman, Usama Gergis
Transformation of a Chronic Myeloproliferative Neoplasm to Acute Myelogenous Leukemia: Does Anything Work?
Madappa N. Kundranda, Raoul Tibes, Ruben A. Mesa